NEW YORK (GenomeWeb) – Centogene, a German firm focusing on genetic diagnosis of rare disease, has raised €25 million ($28 million) in a Series A financing round led by TVM Capital Life Science in collaboration with DPE Deutsche Private Equity, Careventures, and CIC Capital.

Centogene said it will use the proceeds from the financing to accelerate its growth and expansion plans in the areas of genetic testing, pharmaceutical collaborations, and big-data solutions.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jun
14
Sponsored by
Sophia Genetics

This webinar will discuss an effort underway at the University of North Carolina Medical Center's to overcome limitations in the hematological genomic testing workflow with artificial intelligence (AI) from Sophia Genetics.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
26
Sponsored by
Lexogen

This webinar outlines a study that sought to characterize the landscape of alternative polyadenylation (APA) in the lung cancer transcriptome in order to gain insight into the role of APA in cancer progression.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.